Prostate cancer (PCa) is most commonly diagnosed by a prostate biopsy followed by a histopathology, a rectal examination, magnetic resonance imaging, a transrectal ultrasound, and PSA (prostatic-specific antigen) detection [6,7]. This evidence concerns the gene KLK3 and prostate carcinoma.